Holdings of SUPERSTRING CAPITAL MANAGEMENT LP
32 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 62.2 % of the equity sleeve
Sector breakdown
- Health care 11.5 %
- Unattributed 88.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 89.4 %
- KY 6.4 %
- DK 4.2 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 29 | 112.1M $ | 89.36 % |
| KY | 2 | 8.1M $ | 6.43 % |
| DK | 1 | 5.3M $ | 4.21 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Summit Therapeutics Inc | 892,873 | 16.9M $ | |
| Immunovant Inc | 357,606 | 8.9M $ | |
| Cogent Biosciences Inc | 225,158 | 8.7M $ | |
| Savara Inc | 1,585,977 | 8.7M $ | |
| Vir Biotechnology Inc | 730,548 | 6.5M $ | |
| Vaxcyte Inc | 110,454 | 6.4M $ | |
| Celldex Therapeutics Inc | 180,048 | 5.7M $ | |
| Sionna Therapeutics Inc | 141,024 | 5.7M $ | |
| Genmab A/S | 196,709 | 5.3M $ | |
| ZAI LAB LTD | 275,818 | 5.2M $ | |
| Vertex Pharmaceuticals Inc | 11,010 | 4.9M $ | |
| IQVIA Holdings Inc | 25,668 | 4.4M $ | |
| MapLight Therapeutics Inc | 192,139 | 3.9M $ | |
| Arvinas Inc | 312,620 | 3.3M $ | |
| Oruka Therapeutics Inc | 63,591 | 3.1M $ | |
| United Therapeutics Corp | 5,186 | 3.1M $ | |
| Travere Therapeutics Inc | 102,754 | 3.1M $ | |
| Trevi Therapeutics Inc | 251,566 | 3M $ | |
| Adlai Nortye Ltd. | 414,852 | 2.9M $ | |
| Cabaletta Bio Inc | 1,066,239 | 2.9M $ | |
| Pfizer Inc | 74,000 | 2.1M $ | |
| Axsome Therapeutics Inc | 11,217 | 1.9M $ | |
| ORIC Pharmaceuticals Inc | 115,234 | 1.5M $ | |
| Aclaris Therapeutics Inc | 366,490 | 1.4M $ | |
| Climb Bio Inc | 199,209 | 1.4M $ | |
| Taysha Gene Therapies Inc | 258,269 | 1.2M $ | |
| Tonix Pharmaceuticals Holding Corp | 63,540 | 873.7K $ | |
| Cullinan Therapeutics Inc | 59,484 | 845.3K $ | |
| Protara Therapeutics Inc | 121,457 | 632.8K $ | |
| PALATIN TECHNOLOGIES INC | 35,969 | 626.6K $ | |
| BIOMEA FUSION INC | 250,000 | 382.5K $ | |
| Century Therapeutics Inc | 119,308 | 269.6K $ | |